APA (7th ed.) Citation

KY, I., RM, M., CFD, S., TMV, S., JC, B., MIM, P., . . . AMC, S. (2024). Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons. Revista do Instituto de Medicina Tropical de Sao Paulo, 66, e24. https://doi.org/10.1590/S1678-9946202466024

Chicago Style (17th ed.) Citation

KY, Ibrahim, et al. "Immunogenicity of COVID-19 Adsorbed Inactivated Vaccine (CoronaVac) and Additional Doses of MRNA BNT162b2 Vaccine in Immunocompromised Adults Compared with Immunocompetent Persons." Revista Do Instituto De Medicina Tropical De Sao Paulo 66 (2024): e24. https://doi.org/10.1590/S1678-9946202466024.

MLA (9th ed.) Citation

KY, Ibrahim, et al. "Immunogenicity of COVID-19 Adsorbed Inactivated Vaccine (CoronaVac) and Additional Doses of MRNA BNT162b2 Vaccine in Immunocompromised Adults Compared with Immunocompetent Persons." Revista Do Instituto De Medicina Tropical De Sao Paulo, vol. 66, 2024, p. e24, https://doi.org/10.1590/S1678-9946202466024.